Type 2 diabetes patients who received the highest doses of an experimental injectable drug called LY attained significant reductions in bad cholesterol and triglyceride rates and increased good cholesterol levels compared with those who received placebo shots, according to a small study in Cell Metabolism. Researchers said the drug, a copy of the fibroblast growth factor 21 hormone, appears to inhibit obesity and improve insulin action.

Related Summaries